585 related articles for article (PubMed ID: 29454180)
1. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
2. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
[TBL] [Abstract][Full Text] [Related]
3. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
4. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
[No Abstract] [Full Text] [Related]
5. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
6. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
7. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
9. A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-naïve major depressive disorder.
Chiu YC; Yang BH; Yang KC; Liu MN; Hu LY; Liou YJ; Chan LY; Chou YH
Psychiatry Res Neuroimaging; 2021 Jun; 312():111296. PubMed ID: 33945927
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan and Kynurenine Metabolites: Are They Related to Depression?
Pompili M; Lionetto L; Curto M; Forte A; Erbuto D; Montebovi F; Seretti ME; Berardelli I; Serafini G; Innamorati M; Amore M; Baldessarini RJ; Girardi P; Simmaco M
Neuropsychobiology; 2019; 77(1):23-28. PubMed ID: 30110684
[TBL] [Abstract][Full Text] [Related]
11. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
12. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L
Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
14. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
[TBL] [Abstract][Full Text] [Related]
16. The possible role of the kynurenine pathway in adolescent depression with melancholic features.
Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L
J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333
[TBL] [Abstract][Full Text] [Related]
17. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.
Ogawa S; Fujii T; Koga N; Hori H; Teraishi T; Hattori K; Noda T; Higuchi T; Motohashi N; Kunugi H
J Clin Psychiatry; 2014 Sep; 75(9):e906-15. PubMed ID: 25295433
[TBL] [Abstract][Full Text] [Related]
18. Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls.
Sun N; Lei L; Wang Y; Yang C; Liu Z; Li X; Zhang K
J Affect Disord; 2016 Apr; 194():109-14. PubMed ID: 26807671
[TBL] [Abstract][Full Text] [Related]
19. Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
Wang L; Yang P; Yang C; Yang D; Wu X; Cao T; Zeng C; Chen Q; Zhang S; Zhu Z; Jiao S; Cai H
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1283-1296. PubMed ID: 35410391
[TBL] [Abstract][Full Text] [Related]
20. The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.
Bradley KA; Case JA; Khan O; Ricart T; Hanna A; Alonso CM; Gabbay V
Psychiatry Res; 2015 Jun; 227(2-3):206-12. PubMed ID: 25865484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
